Frauke Picard1, Petroula Panagiotidou2, Laura Weinig2, Maximilian Steffen2, Anne-Beke Tammen2, Rolf Michael Klein2,3. 1. Department of Cardiology, Augusta Hospital Düsseldorf, Academic Teaching Hospital of the University, Faculty of Health, Amalienstraße 9, Düsseldorf, Germany. Frauke.Picard@vkkd-kliniken.de. 2. Department of Cardiology, Augusta Hospital Düsseldorf, Academic Teaching Hospital of the University, Faculty of Health, Amalienstraße 9, Düsseldorf, Germany. 3. Department of Cardiology, University Hospital Witten/Herdecke, Witten, Germany.
Abstract
PURPOSE: Obstructive sleep apnea (OSA) can induce dramatic nocturnal blood pressure fluctuations (NBPFs) and can be associated with nocturnal hypertension and arterial stiffness. We investigated the effect of short- and long-term continuous positive airway pressure (CPAP) therapy on NBPFs, nocturnal blood pressure (BP), and arterial stiffness in patients with coexisting cardiovascular diseases (CVD) and OSA (CVD/OSA). METHODS: Of 86 patients with CVD, 58 also had OSA, while 28 without OSA served as controls. Nighttime BP was measured continuously using pulse transit time (PTT) and arterial stiffness was measured with pulse wave velocity (PWV). A NBPF was defined as systolic BP elevation > 12 mmHg in a 30 s interval of sleep. All measurements were conducted at baseline, after the first night of CPAP, and after 6 months of CPAP therapy. RESULTS: In CVD/OSA patients, we observed significantly more frequent NBPFs (p < 0.001) compared with controls. CPAP therapy decreased the frequency of NBPFs (p < 0.001), the maximum systolic BP by 9 mmHg (p = 0.021), and PWV (p < 0.001) even after the first night. After long-term CPAP therapy, there was an additional decrease in average nocturnal systolic BP by 10 mmHg (p = 0.039). CONCLUSIONS: Our findings demonstrate that CPAP therapy reduces NBPFs, nocturnal BP, and arterial stiffness in CVD/OSA patients. This effect was demonstrable after the first night of CPAP and grew more robust after 6 months of CPAP therapy.
PURPOSE:Obstructive sleep apnea (OSA) can induce dramatic nocturnal blood pressure fluctuations (NBPFs) and can be associated with nocturnal hypertension and arterial stiffness. We investigated the effect of short- and long-term continuous positive airway pressure (CPAP) therapy on NBPFs, nocturnal blood pressure (BP), and arterial stiffness in patients with coexisting cardiovascular diseases (CVD) and OSA (CVD/OSA). METHODS: Of 86 patients with CVD, 58 also had OSA, while 28 without OSA served as controls. Nighttime BP was measured continuously using pulse transit time (PTT) and arterial stiffness was measured with pulse wave velocity (PWV). A NBPF was defined as systolic BP elevation > 12 mmHg in a 30 s interval of sleep. All measurements were conducted at baseline, after the first night of CPAP, and after 6 months of CPAP therapy. RESULTS: In CVD/OSA patients, we observed significantly more frequent NBPFs (p < 0.001) compared with controls. CPAP therapy decreased the frequency of NBPFs (p < 0.001), the maximum systolic BP by 9 mmHg (p = 0.021), and PWV (p < 0.001) even after the first night. After long-term CPAP therapy, there was an additional decrease in average nocturnal systolic BP by 10 mmHg (p = 0.039). CONCLUSIONS: Our findings demonstrate that CPAP therapy reduces NBPFs, nocturnal BP, and arterial stiffness in CVD/OSA patients. This effect was demonstrable after the first night of CPAP and grew more robust after 6 months of CPAP therapy.
Authors: Lorenzo Loffredo; Anna Maria Zicari; Francesca Occasi; Ludovica Perri; Roberto Carnevale; Francesco Angelico; Maria Del Ben; Francesco Martino; Cristina Nocella; Vincenzo Savastano; Azzurra Cesoni Marcelli; Marzia Duse; Francesco Violi Journal: Atherosclerosis Date: 2015-03-18 Impact factor: 5.162
Authors: Lourdes Lozano; José Luis Tovar; Gabriel Sampol; Odile Romero; María José Jurado; Alfons Segarra; Eugènia Espinel; José Ríos; María Dolores Untoria; Patrícia Lloberes Journal: J Hypertens Date: 2010-10 Impact factor: 4.844
Authors: Miguel-Angel Martínez-García; Francisco Capote; Francisco Campos-Rodríguez; Patricia Lloberes; María Josefa Díaz de Atauri; María Somoza; Juan F Masa; Mónica González; Lirios Sacristán; Ferrán Barbé; Joaquín Durán-Cantolla; Felipe Aizpuru; Eva Mañas; Bienvenido Barreiro; Mar Mosteiro; Juan J Cebrián; Mónica de la Peña; Francisco García-Río; Andrés Maimó; Jordi Zapater; Concepción Hernández; Nuria Grau SanMarti; Josep María Montserrat Journal: JAMA Date: 2013-12-11 Impact factor: 56.272
Authors: Rodrigo P Pedrosa; Luciano F Drager; Lílian K G de Paula; Aline C S Amaro; Luiz A Bortolotto; Geraldo Lorenzi-Filho Journal: Chest Date: 2013-11 Impact factor: 9.410
Authors: José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen Journal: Lancet Date: 2007-10-06 Impact factor: 79.321
Authors: Frauke Picard; Petroula Panagiotidou; Anne-Beke Tammen; Anamaria Wolf-Pütz; Maximilian Steffen; Hanno Julian Gerhardy; Sebastian Waßenberg; Rolf Michael Klein Journal: J Clin Sleep Med Date: 2022-02-01 Impact factor: 4.062